Detalhe da pesquisa
1.
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
Blood
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38684038
2.
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.
Blood
; 141(13): 1584-1596, 2023 03 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36375120
3.
BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL.
Blood
; 138(19): 1843-1854, 2021 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34046681
4.
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Blood
; 137(2): 185-189, 2021 01 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33259596
5.
MARCKS affects cell motility and response to BTK inhibitors in CLL.
Blood
; 138(7): 544-556, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33735912
6.
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Blood
; 136(1): 93-105, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32202637
7.
Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.
Haematologica
; 107(6): 1335-1346, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34587719
8.
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.
Blood
; 132(5): 521-532, 2018 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29743179
9.
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.
Blood
; 131(21): 2357-2366, 2018 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29483101
10.
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
J Immunol
; 201(7): 1967-1974, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30104242
11.
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL.
Int J Mol Sci
; 21(1)2019 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31861854
12.
Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia.
Br J Haematol
; 200(2): 261-263, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36366824
13.
Preventing infectious complications in chronic lymphocytic leukemia.
Clin Adv Hematol Oncol
; 21(12): 676-677, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38039062
14.
COVID-19 vaccine response in chronic lymphocytic leukaemia is more than just seroconversion.
Br J Haematol
; 197(1): 11-12, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35029303
15.
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.
Blood
; 126(19): 2213-9, 2015 11 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26337493
16.
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
Haematologica
; 102(5): 874-882, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28154084
17.
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica
; 100(12): 1571-8, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26430171
18.
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
Am J Hematol
; 95(11): E310-E313, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32808680
19.
Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphoma.
Cancer Treat Res
; 165: 147-75, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25655609
20.
Vaccinations in patients with chronic lymphocytic leukemia.
Semin Hematol
; 2024 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38302313